Not Signed In - All Topic Areas
1 - 10 of 23 more >>
News
1 - 2 of 2
- Neurocrine Biosciences Announces Results From Follow-Up Phase II Study With Its Orally Active GnRH Receptor Antagonist In Endometriosis
MedicalNewsToday - Wed, 13 Sep 2006 07:00 EST
- Positive Phase II Results With Orally Active GnRH Receptor Antagonist In Endometriosis - Neurocrine Biosciences Inc
MedicalNewsToday - Sun, 30 Apr 2006 06:00 EST
Clinical Trials
1 - 5 of 10 more >>
- NBI-3001 Followed by Surgery in Treating Patients With Recurrent Glioblastoma Multiforme
ClinicalTrials.gov Identifier: NCT00014677 - Active, not recruiting
recurrent adult brain tumor; adult glioblastoma multiforme
- Randomised Trial of NBI for Adenoma Detection
ClinicalTrials.gov Identifier: NCT00279357 - Recruiting
Adenomas
- An Exploratory Study of NBI-34060 Capsules and Next Day Functioning
ClinicalTrials.gov Identifier: NCT00525941 - Recruiting
Insomnia
- Adenoma Detection Rate:NBI, AFI, Chromoscopic or Standard Endoscopy
ClinicalTrials.gov Identifier: NCT00253812 - Recruiting
Familial Adenomatous Polyposis
- Endometriosis Trial: Study of NBI-56418 in Endometriosis
ClinicalTrials.gov Identifier: NCT00109512 - Completed
Endometriosis
email this page
print this page
bookmark this page
feedback on this page
